Thus, the surrogate definition of BC molecular subtypes is based on immunohistochemistry (IHC) expression of three main protein markers; the estrogen receptor (ER), the progesterone receptor (PR), and the overexpression of human epidermal growth factor receptor-2 (HER-2/neu). This evidence concerns the gene ESR1 and breast cancer.